IP Library › Granted Patent US 7,252,971
Granted Patent B2
US 7,252,971 · App. 11/234,011 · Granted Aug 7, 2007

IL-23p40 specific immunoglobulin derived proteins

Assignee: Centocor, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,252,971
App. No.
11/234,011
Granted
Aug 7, 2007
Kind
B2
Abstract

An anti-IL-23 specific human Ig derived protein is useful in therapeutic and diagnostic compositions, methods and devices. The anti-IL-23 Ig derived protein preferably includes one or more of the Seg 1, Seg 2, and Seg 3 epitopes of the p40 subunit of IL-23.

Claims (1)

1. An isolated polypeptide comprising the murine IL-23 protein, wherein the Murineseg 2 of murine IL-23p40 is replaced by the amino acid sequence of Seg 2 of human IL-23p40.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2005
From: BENSON, JACQUELINE; CUNNINGHAM, MARK; LUO, JEFFREY
To: CENTOCOR, INC.
Reel/Frame 017308/0923 →
Continuity (3)
Provisional Application 6061683200 · Oct 7, 2004
Provisional Application 6061286600 · Sep 24, 2004
Related Publication 20060067936A1 · Mar 30, 2006